Von Willebrand disease (vWD) is the most common inherited genetic bleeding disorder, yet it is not well known or understood among the public or healthcare providers. Von Willebrand factor (vWF) is a protein that is essential for platelet aggregation and clotting. A low vWF can lead to heavy or prolonged bleeding. This most commonly appears as complaints of menorrhagia (i.e., heavy menstrual bleeding), prolonged bleeding after minor injuries, or gum bleeding. The clinician can advocate for proper diagnosis and treatment, as well as prevent adverse events by being aware of the presenting signs and types of the disorder, recognizing that many patients are asymptomatic, and understanding when a hematology consultation is warranted.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
South Carolina Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Tennessee Medical Laboratory Board (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Relias LLC is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Understanding von Willebrand Disease
Overview
Hemostasis and von Willebrand Factor
The Profile
Clinical Work-Up
Quality-of-Life Issues
vWD Treatments
Educational Needs
Section 3: Clinical Vignette
Section 4: Conclusion
Course Summary
Course Contributor(s)
Resources
References
Subject Matter Expert: Christopher Reist, MD, MBANicole Strickland, BA, BSN, RN, CPAN has cared for patients at every acuity level over more than a decade as a nurse. She has devoted much of her nursing career to training nurses and nursing students as a Certified Post Anesthesia Nurse (CPAN). She holds a BA in English Language and Literature from Temple University and worked as a medical editor for the National Board of Medical Examiners before returning to school to obtain a BSN from Duke University. She is now pursuing a M.Ed. in Learning Design and Technology from The University of North Carolina at Charlotte while continuing her passion for the creation of evidence-based and engaging education as an acute care SME writer at Relias.
Dr. Reist is Professor Emeritus in the Department of Psychiatry and Human Behavior at the University of California, Irvine. He has served as Assistant Dean in the College of Medicine and the Director of Medical Research for the Long Beach Veterans Affairs Healthcare System. Formerly, he served as Chief of Mental Health, overseeing full service mental health care delivery to over 50,000 enrollees at the Long Beach VA Healthcare System. He was the Associate Director of the Southern California VA Mental Illness Research, Education, and Clinical Center (MIRECC), which is focused on improving long-term outcomes in chronic psychotic disorders through basic/clinical research and dissemination of evidence-based practices. Dr. Reist’s clinical interests include schizophrenia, impulsivity, PTSD, pharmacogenomics, and psychopharmacology. DoD, NIMH, and VA Medical Research have supported his research. Dr. Reist is a Distinguished Fellow of the Psychiatric Association, has been recognized as an Exemplary Psychiatrist by the National Alliance for the Mentally Ill, and is included in Best Doctors 2007-2019. He is the author of two books and over 75 original scientific articles.Subject Matter Expert: Catherine J. Swift, MT(ASCP)
Catherine Swift, MT(ASCP) is the clinical laboratory science editor for Relias Learning. She has a Bachelor of Arts in English from Hastings College and a Bachelor of Science in Medical Technology from North Colorado Medical Center. She has experience working in hospital laboratories, clinic laboratories, and research experience in microbiology as well as clinical research trials involving patients and various drug therapies for osteoporosis, endometriosis and bone density at Creighton University School of Medicine.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.